, Hong Kong
487 views
AstraZeneca

AstraZeneca unveils new R&D centre in Hong Kong

The R&D centre will focus on cell and gene therapy studies.

UK-based biopharmaceutical company AstraZeneca has launched a research and development (R&D) centre in Hong Kong.

The R&D centre in Hong Kong will focus on research and development of medicines in cell and gene therapy.

AstraZeneca also launched the Hong Kong iCampus, which will assist startups to broaden the medical innovation ecosystem.

AstraZeneca also organised a group of 80 Mainland pharmaceutical and biotechnology enterprises to visit Hong Kong. 

The group comprises large-scale listed enterprises and startups engaging in pioneering pharmaceutical technologies.

Follow the link for more news on

Join Hong Kong Business community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you design and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

Education demand opens opportunity for Hong Kong commercial landlords: Colliers
Rising non-local student demand is creating a window to convert underused office and retail space into education facilities.
OCBC rolls out free ESG assessment tool for SMEs
Large companies can request to onboard their SME suppliers.
Jobless rate steady at 3.7% in March to May
The underemployment rate also remained unchanged at 1.5%, whilst total employment slipped slightly.
Economy